Literature DB >> 15915330

[New concepts for surgical therapy of cervical carcinoma].

M Höckel1.   

Abstract

Abdominal radical hysterectomy (Wertheim operation) is the current standard of surgical therapy of cervical carcinoma. It is based on historical concepts of female pelvic anatomy and locoregional tumor spread. This surgical therapy - depending on the individual radicality of the operation - leads to damage of essential structures not involved by the tumor, e.g. the autonomic pelvic nerves. Despite of its supposed radicality the Wertheim operation has to be combined with adjuvant radiotherapy in case of histopathological high risk factors to reach acceptable rates of tumor control. The total mesometrial resection (TMMR) uses new insights in pelvic anatomy and local tumor spread derived from developmental biology for a new concept of radicality achieving a high regional control rate with minimal treatment-related morbidity without adjuvant radiotherapy.

Entities:  

Mesh:

Year:  2005        PMID: 15915330     DOI: 10.1007/s00292-005-0762-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  24 in total

1.  Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III.

Authors:  M Possover; S Stöber; K Plaul; A Schneider
Journal:  Gynecol Oncol       Date:  2000-11       Impact factor: 5.482

2.  Diversity, topographic differentiation, and positional memory in human fibroblasts.

Authors:  Howard Y Chang; Jen-Tsan Chi; Sandrine Dudoit; Chanda Bondre; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-24       Impact factor: 11.205

3.  Protocol for the examination of specimens from patients with carcinomas of the cervix: a basis for checklists. Cancer Committee, College of American Pathologists.

Authors:  R J Kurman; M B Amin
Journal:  Arch Pathol Lab Med       Date:  1999-01       Impact factor: 5.534

4.  Surgically-treated early cervical cancer: Prognostic factors and the significance of depth of tumor invasion.

Authors:  B. W. J. Hellebrekers; A. H. Zwinderman; G. G. Kenter; A. A. W. Peters; A. Snijders-Keilholz; G. C. M. Graziosi; G. J. Fleuren; J. B. Trimbos
Journal:  Int J Gynecol Cancer       Date:  1999-05       Impact factor: 3.437

5.  Development and distribution of adipose tissue in the human pelvis.

Authors:  H Fritsch; W Kühnel
Journal:  Early Hum Dev       Date:  1992-01       Impact factor: 2.079

6.  Five classes of extended hysterectomy for women with cervical cancer.

Authors:  M S Piver; F Rutledge; J P Smith
Journal:  Obstet Gynecol       Date:  1974-08       Impact factor: 7.661

7.  A glossary for reporting complications of treatment in gynecological cancers.

Authors:  D Chassagne; P Sismondi; J C Horiot; G Sinistrero; P Bey; P Zola; M Pernot; A Gerbaulet; I Kunkler; G Michel
Journal:  Radiother Oncol       Date:  1993-03       Impact factor: 6.280

8.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

9.  Total mesometrial resection: high resolution nerve-sparing radical hysterectomy based on developmentally defined surgical anatomy.

Authors:  M Höckel; L-C Horn; B Hentschel; S Höckel; G Naumann
Journal:  Int J Gynecol Cancer       Date:  2003 Nov-Dec       Impact factor: 3.437

Review 10.  Clinical anatomy of the pelvic floor.

Authors:  H Fritsch; A Lienemann; E Brenner; B Ludwikowski
Journal:  Adv Anat Embryol Cell Biol       Date:  2004       Impact factor: 1.231

View more
  1 in total

1.  ERK-mediated autophagy promotes inactivated Sendai virus (HVJ-E)-induced apoptosis in HeLa cells in an Atg3-dependent manner.

Authors:  Tao Wang; Ning Yu; Miao Qian; Jie Feng; Shuyang Cao; Jun Yin; Quan Zhang
Journal:  Cancer Cell Int       Date:  2018-12-04       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.